SCHEMBL16214742

SCHEMBL16214742

O=CCC1(O)CC[C@@H](C(=O)OCc2ccccc2)C1

nearest known ligand 0.44

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
FKBP1A P62942 6/20 0.41
TSHR P16473 2/20 0.41
ALDH1A1 P00352 1/20 0.40
GAA P10253 1/20 0.40
FABP7 O15540 1/20 0.40
FABP5 Q01469 1/20 0.40
HPGD P15428 1/20 0.40
DDB1 Q16531 1/20 0.40
CRBN Q96SW2 1/20 0.40
CYP2C19 P33261 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16214739 0.89 SMN1; SMN2 (0.40) SMN1; SMN2NPC1RAB9ATSHRALDH1A1
SCHEMBL1666432 0.89 SMN1; SMN2 (0.40) SMN1; SMN2NPC1RAB9ATSHRALDH1A1
SCHEMBL1668432 0.84 SMN1; SMN2 (0.43) SMN1; SMN2NPC1RAB9AFKBP1ATSHR
SCHEMBL1666476 0.84 SMN1; SMN2 (0.43) SMN1; SMN2NPC1RAB9AFKBP1ATSHR
SCHEMBL16214732 0.84 FKBP1A (0.46) FKBP1ATSHRALDH1A1FABP7FABP5
SCHEMBL16214760 0.84 FKBP1A (0.46) FKBP1ATSHRALDH1A1FABP7FABP5
SCHEMBL1813152 0.81 FABP7 (0.42) SMN1; SMN2NPC1RAB9AFKBP1ATSHR
SCHEMBL28922840 0.81 FABP7 (0.44) SMN1; SMN2NPC1RAB9ATSHRALDH1A1
SCHEMBL6120052 0.80 SMN1; SMN2 (0.46) SMN1; SMN2NPC1RAB9AFKBP1ATSHR
SCHEMBL15457715 0.79 SLC6A2 (0.45) SMN1; SMN2NPC1RAB9AFKBP1ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9221819-B2 Spirocyclic compounds as modulators of chemokine receptor activity BRISTOL-MYERS SQUIBB COMPANY (US) 2015-12-29 US disclosed
US-8877749-B2 Spirocyclic compounds as modulators of chemokine receptor activity Bristol-Myers Squibbs Company (US) 2014-11-04 US disclosed
CN-102648193-A Spiro compounds as modulators of chemokine receptor activity BRISTOL MYERS SQUIBB CO 2012-08-22 CN disclosed